Your browser doesn't support javascript.
loading
gsSKAT: Rapid gene set analysis and multiple testing correction for rare-variant association studies using weighted linear kernels.
Larson, Nicholas B; McDonnell, Shannon; Cannon Albright, Lisa; Teerlink, Craig; Stanford, Janet; Ostrander, Elaine A; Isaacs, William B; Xu, Jianfeng; Cooney, Kathleen A; Lange, Ethan; Schleutker, Johanna; Carpten, John D; Powell, Isaac; Bailey-Wilson, Joan E; Cussenot, Olivier; Cancel-Tassin, Geraldine; Giles, Graham G; MacInnis, Robert J; Maier, Christiane; Whittemore, Alice S; Hsieh, Chih-Lin; Wiklund, Fredrik; Catalona, William J; Foulkes, William; Mandal, Diptasri; Eeles, Rosalind; Kote-Jarai, Zsofia; Ackerman, Michael J; Olson, Timothy M; Klein, Christopher J; Thibodeau, Stephen N; Schaid, Daniel J.
Afiliação
  • Larson NB; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
  • McDonnell S; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Cannon Albright L; Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
  • Teerlink C; Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
  • Stanford J; Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Ostrander EA; National Human Genome Research Institute, Bethesda, Maryland, United States of America.
  • Isaacs WB; Brady Urological Institute, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Xu J; NorthShore University HealthSystem Research Institute, Chicago, Illinois, United States of America.
  • Cooney KA; Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
  • Lange E; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.
  • Schleutker J; Department of Urology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.
  • Carpten JD; Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, United States of America.
  • Powell I; Department of Medical Biochemistry and Genetics, Institute of Biomedicine, University of Turku, Turku, Finland.
  • Bailey-Wilson JE; Department of Translational Genomics, University of Southern California, Los Angeles, California, United States of America.
  • Cussenot O; Department of Urology, Wayne State University, Detroit, Michigan, United States of America.
  • Cancel-Tassin G; Statistical Genetics Section, National Human Genome Research Institute, Bethesda, Maryland, United States of America.
  • Giles GG; CeRePP, Hopital Tenon, Paris, France.
  • MacInnis RJ; CeRePP, Hopital Tenon, Paris, France.
  • Maier C; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia.
  • Whittemore AS; Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, Australia.
  • Hsieh CL; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia.
  • Wiklund F; Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, Australia.
  • Catalona WJ; Department of Urology, University of Ulm, Ulm, Germany.
  • Foulkes W; Department of Health Research and Policy, Stanford University, Stanford, California, United States of America.
  • Mandal D; Department of Urology, University of Southern California, Los Angeles, California, United States of America.
  • Eeles R; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Kote-Jarai Z; Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.
  • Ackerman MJ; Department of Oncology, Montreal General Hospital, Montreal, Quebec, Canada.
  • Olson TM; Department of Human Genetics, Montreal General Hospital, Montreal, Quebec, Canada.
  • Klein CJ; Department of Genetics, LSU Health Sciences Center, New Orleans, Louisiana, United States of America.
  • Thibodeau SN; The Institute of Cancer Research, London, UK.
  • Schaid DJ; The Institute of Cancer Research, London, UK.
Genet Epidemiol ; 41(4): 297-308, 2017 05.
Article em En | MEDLINE | ID: mdl-28211093
ABSTRACT
Next-generation sequencing technologies have afforded unprecedented characterization of low-frequency and rare genetic variation. Due to low power for single-variant testing, aggregative methods are commonly used to combine observed rare variation within a single gene. Causal variation may also aggregate across multiple genes within relevant biomolecular pathways. Kernel-machine regression and adaptive testing methods for aggregative rare-variant association testing have been demonstrated to be powerful approaches for pathway-level analysis, although these methods tend to be computationally intensive at high-variant dimensionality and require access to complete data. An additional analytical issue in scans of large pathway definition sets is multiple testing correction. Gene set definitions may exhibit substantial genic overlap, and the impact of the resultant correlation in test statistics on Type I error rate control for large agnostic gene set scans has not been fully explored. Herein, we first outline a statistical strategy for aggregative rare-variant analysis using component gene-level linear kernel score test summary statistics as well as derive simple estimators of the effective number of tests for family-wise error rate control. We then conduct extensive simulation studies to characterize the behavior of our approach relative to direct application of kernel and adaptive methods under a variety of conditions. We also apply our method to two case-control studies, respectively, evaluating rare variation in hereditary prostate cancer and schizophrenia. Finally, we provide open-source R code for public use to facilitate easy application of our methods to existing rare-variant analysis results.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Variação Genética / Algoritmos / Estudos de Associação Genética Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Genet Epidemiol Assunto da revista: EPIDEMIOLOGIA / GENETICA MEDICA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Variação Genética / Algoritmos / Estudos de Associação Genética Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Genet Epidemiol Assunto da revista: EPIDEMIOLOGIA / GENETICA MEDICA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos